Sangamo Therapeutics
SGMO
#8764
Rank
โ‚น14.58 B
Marketcap
โ‚น43.35
Share price
-4.11%
Change (1 day)
-74.45%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: โ‚น14.58 Billion

As of December 2025 Sangamo Therapeutics has a market cap of โ‚น14.58 Billion. This makes Sangamo Therapeutics the world's 8764th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น14.58 B-68.16%
2024โ‚น45.82 B471.25%
2023โ‚น8.02 B-81.16%
2022โ‚น42.58 B-47.64%
2021โ‚น81.32 B-49.62%
2020โ‚น161.42 B133.2%
2019โ‚น69.22 B-15.61%
2018โ‚น82.02 B-7.32%
2017โ‚น88.50 B504.65%
2016โ‚น14.63 B-65.71%
2015โ‚น42.68 B-35.88%
2014โ‚น66.57 B24.64%
2013โ‚น53.41 B205.92%
2012โ‚น17.45 B121.48%
2011โ‚น7.88 B-41.61%
2010โ‚น13.50 B9.24%
2009โ‚น12.35 B80.31%
2008โ‚น6.85 B-66.73%
2007โ‚น20.60 B101.1%
2006โ‚น10.24 B84.78%
2005โ‚น5.54 B-15.57%
2004โ‚น6.56 B5.66%
2003โ‚น6.21 B74.03%
2002โ‚น3.57 B-67.63%
2001โ‚น11.03 B-45.26%
2000โ‚น20.15 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Sangamo Therapeutics was reported to be:

โ‚น15.21 Billion
by Nasdaq info icon info icon
โ‚น15.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
โ‚น13.525 T 92,613.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น4.800 T 32,804.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น15.256 T 104,477.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น2.339 T 15,939.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚น1.570 T 10,662.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น44.703 T 306,328.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น926.78 B 6,252.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น21.904 T 150,051.03%๐Ÿ‡บ๐Ÿ‡ธ USA